BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pediatric Endocrine Society
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230914T180000
DTEND;TZID=America/New_York:20230914T190000
DTSTAMP:20230906T173016Z
CREATED:20230906T172734Z
LAST-MODIFIED:20230906T173016Z
UID:22881-1694714400-1694718000@pedsendo.org
SUMMARY:Industry Sponsored Symposia - Achondroplasia a Multidisciplinary Conversation on Comprehensive Care
DESCRIPTION:Title: Achondroplasia a Multidisciplinary Conversation on Comprehensive Care \nDate: Thursday\, September 14 from 6:00 – 7:00pm EST \nSummary of Session:\nAchondroplasia (Ach)\, the most common skeletal dysplasia with disproportionate short stature\, is characterized by a number of medical\, functional\, and psychosocial challenges across the lifespan of an individual. Up until recently\, the treatment of the developmental complications of Ach involved only symptomatic management\, surgical intervention\, and lifelong follow-up care. An improved understanding of the molecular pathways involved in Ach has resulted in the development of new and emerging targeted therapies for this condition. These novel agents aim to restore bone growth and prevent many of the medical conditions associated with Ach. In this virtual live symposium\, an expert panel will address the complications associated with Ach\, current care recommendations\, strategies for coordination of care with specialists\, and new and emerging therapies for Ach.\n \nSpeakers: \n\nAndrew Dauber\, MD\, MMSc\, Chief of Endocrinology\, Children’s National Hospital\, Washington\, DC\nNadia Merchant\, MD\, Assistant Professor of Pediatrics\, Division of Endocrinology and Diabetes\, Children’s National Hospital\, Washington\, DC\nWilliam G. Mackenzie\, MD\, FRCS(c)\, FAAOS\, Chairman\, Department of Orthopedic Surgery\, Nemours Children’s Health\, Wilmington\, DE\n\n\n\nSponsored by BioMarin Pharmaceutical Inc.
URL:https://pedsendo.org/event/industry-sponsored-symposia-achondroplasia-a-multidisciplinary-conversation-on-comprehensive-care/
END:VEVENT
END:VCALENDAR